CRISPR-cas System as a Genome Engineering Platform: Applications in Biomedicine and Biotechnology

Author(s): Atieh Hashemi*

Journal Name: Current Gene Therapy

Volume 18 , Issue 2 , 2018

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer
Call for Editor


Genome editing mediated by Clustered Regularly Interspaced Palindromic Repeats (CRISPR) and its associated proteins (Cas) has recently been considered to be used as efficient, rapid and site-specific tool in the modification of endogenous genes in biomedically important cell types and whole organisms. It has become a predictable and precise method of choice for genome engineering by specifying a 20-nt targeting sequence within its guide RNA. Firstly, this review aims to describe the biology of CRISPR system. Next, the applications of CRISPR–Cas9 in various ways, such as efficient generation of a wide variety of biomedically important cellular models as well as those of animals, modifying epigenomes, conducting genome-wide screens, gene therapy, labelling specific genomic loci in living cells, metabolic engineering of yeast and bacteria and endogenous gene expression regulation by an altered version of this system were reviewed.

Keywords: CRISPR, Genome engineering, Biology, Applications, Cas9, Biomedicine, Biotechnology.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2018
Published on: 07 May, 2018
Page: [115 - 124]
Pages: 10
DOI: 10.2174/1566523218666180221110627
Price: $65

Article Metrics

PDF: 42
PRC: 1